Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 2
2003 3
2004 1
2005 1
2006 4
2007 3
2008 7
2009 8
2010 15
2011 18
2012 9
2013 9
2014 13
2015 10
2016 8
2017 6
2018 3
2019 7
2020 3
2021 5
2022 4
2023 5
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA; BRIM-3 Study Group. Chapman PB, et al. Among authors: jouary t. N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5. N Engl J Med. 2011. PMID: 21639808 Free PMC article. Clinical Trial.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.
Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion-Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Swann S, Legos JJ, Jin F, Mookerjee B, Flaherty K. Long GV, et al. Among authors: jouary t. Lancet. 2015 Aug 1;386(9992):444-51. doi: 10.1016/S0140-6736(15)60898-4. Epub 2015 May 31. Lancet. 2015. PMID: 26037941 Clinical Trial.
[Childhood vitiligo].
Ammour A, Jouary T, Taïeb A, Mazereeuw-Hautier J; Société française de dermatologie pédiatrique. Ammour A, et al. Among authors: jouary t. Ann Dermatol Venereol. 2010 Oct;137(10):654-8; quiz 653. doi: 10.1016/j.annder.2010.07.004. Epub 2010 Sep 16. Ann Dermatol Venereol. 2010. PMID: 20932450 Review. French. No abstract available.
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.
Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Casey M, Ouellet D, Martin AM, Le N, Patel K, Flaherty K. Long GV, et al. Among authors: jouary t. N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29. N Engl J Med. 2014. PMID: 25265492 Free article. Clinical Trial.
Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey.
Kervarrec T, Tallet A, Macagno N, de la Fouchardière A, Pissaloux D, Tirode F, Bravo IG, Nicolas A, Baulande S, Sohier P, Balme B, Osio A, Jullie ML, Moulonguet I, Bonsang B, Tournier E, Herfs M, Frouin E, Zidan A, Calonje E, Berthon P, Touzé A, Seris A, Mortier L, Jouary T, Cribier B, Battistella M. Kervarrec T, et al. Among authors: jouary t. Am J Surg Pathol. 2023 Oct 1;47(10):1096-1107. doi: 10.1097/PAS.0000000000002098. Epub 2023 Jul 31. Am J Surg Pathol. 2023. PMID: 37505808 Free article.
[Linear porokeratosis].
Darrigade AS, Conte H, Ip Kan Fong H, Taïeb A, Jouary T. Darrigade AS, et al. Among authors: jouary t. Ann Dermatol Venereol. 2011 Nov;138(11):800-2. doi: 10.1016/j.annder.2011.06.009. Epub 2011 Aug 23. Ann Dermatol Venereol. 2011. PMID: 22078049 French. No abstract available.
[Microvenular hemangioma].
Jouary T, Chauvel A, Bioulac-Sage P, Taieb A. Jouary T, et al. Ann Dermatol Venereol. 2004 May;131(5):475-7. doi: 10.1016/s0151-9638(04)93643-5. Ann Dermatol Venereol. 2004. PMID: 15235537 French.
[Feverish skin eruption].
Pham-Ledard A, Hubiche T, Truchetet ME, Jouary T, Pellegrin JL, Taieb A. Pham-Ledard A, et al. Among authors: jouary t. Ann Dermatol Venereol. 2009 Jun-Jul;136(6-7):546-8. doi: 10.1016/j.annder.2008.09.025. Epub 2009 Mar 10. Ann Dermatol Venereol. 2009. PMID: 19560621 French. No abstract available.
[Systemic treatment of melanoma brain metastases].
Le Rhun É, Mateus C, Mortier L, Dhermain F, Guillot B, Grob JJ, Lebbe C, Thomas M, Jouary T, Leccia MT, Robert C. Le Rhun É, et al. Among authors: jouary t. Cancer Radiother. 2015 Feb;19(1):48-54. doi: 10.1016/j.canrad.2014.11.010. Epub 2015 Feb 2. Cancer Radiother. 2015. PMID: 25656856 Review. French.
135 results